Cost and Utilization of Immunotherapy and Targeted Therapy for Melanoma: Cross-Sectional Analysis in the Medicare Population, 2013 and 2015

Journal of the American Academy of Dermatology - United States
doi 10.1016/j.jaad.2019.10.023
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

Elsevier BV

Related search

Targeted Therapy and Immunotherapy: Emerging Biomarkers in Metastatic Melanoma

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2020English

Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma

Frontiers in Immunology
AllergyImmunology
2019English

Combining Targeted Therapy With Immunotherapy inBRAF-Mutant Melanoma: Promise and Challenges

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Hepatitis C Virus Screening Trends: Serial Cross-Sectional Analysis of the National Health Interview Survey Population, 2013–2015

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2018English

Variations in Hospice Utilization and Length of Stay for Medicare Patients With Melanoma

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2018English

Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Combining Immunotherapy With Oncogene-Targeted Therapy: A New Road for Melanoma Treatment

Frontiers in Immunology
AllergyImmunology
2015English

Future of Systemic Therapy in Oncourology: Targeted and Immunotherapy

Practical oncology
2019English

Treating Penile Cancer in the Immunotherapy and Targeted Therapy Era

Case Reports in Oncological Medicine
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy